Global Liposome Drug Delivery Competitive Landscape Professional Research Report 2025
Research Summary
Liposome drug delivery is a method of delivering drugs to targeted cells or tissues using liposomes - small, spherical, biocompatible and biodegradable vesicles composed of phospholipids. Liposomes can be loaded with drugs and designed to release the drug in a specific target-controlled manner. The liposomes act as carriers that have the ability to increase the bioavailability of the drug and improve the efficacy of treatment while reducing the toxicity of the drug. Liposome drug delivery is commonly used in the treatment of cancer, infectious diseases, and inflammation. The technology is also useful in enhancing the delivery of large therapeutic molecules, such as peptides, proteins, or nucleic acids, that would otherwise not be adequately absorbed.
According to DIResearch's in-depth investigation and research, the global Liposome Drug Delivery market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Liposome Drug Delivery. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Liposome Drug Delivery market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Liposome Drug Delivery market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Liposome Drug Delivery industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Liposome Drug Delivery Include:
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Liposome Drug Delivery Product Segment Include:
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Liposome Drug Delivery Product Application Include:
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Liposome Drug Delivery Industry PESTEL Analysis
Chapter 3: Global Liposome Drug Delivery Industry Porter’s Five Forces Analysis
Chapter 4: Global Liposome Drug Delivery Major Regional Market Size and Forecast Analysis
Chapter 5: Global Liposome Drug Delivery Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Liposome Drug Delivery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Liposome Drug Delivery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Liposome Drug Delivery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Liposome Drug Delivery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Liposome Drug Delivery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Liposome Drug Delivery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Liposome Drug Delivery Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Liposome Drug Delivery Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Liposome Drug Delivery Product by Type
- 1.2.1 Liposomal Doxorubicin
- 1.2.2 Liposomal Amphoteracin B
- 1.2.3 Liposomal Paclitaxel
- 1.2.4 Others
- 1.3 Liposome Drug Delivery Product by Application
- 1.3.1 Fungal Infection Therapy
- 1.3.2 Cancer & Tumor Therapy
- 1.3.3 Others
- 1.4 Global Liposome Drug Delivery Market Size Analysis (2020-2032)
- 1.5 Liposome Drug Delivery Market Development Status and Trends
- 1.5.1 Liposome Drug Delivery Industry Development Status Analysis
- 1.5.2 Liposome Drug Delivery Industry Development Trends Analysis
- 2 Liposome Drug Delivery Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Liposome Drug Delivery Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Liposome Drug Delivery Market Analysis by Regions
- 4.1 Liposome Drug Delivery Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Liposome Drug Delivery Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Liposome Drug Delivery Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Liposome Drug Delivery Revenue Forecast by Region (2026-2032)
- 5 Global Liposome Drug Delivery Market Size by Type and Application
- 5.1 Global Liposome Drug Delivery Market Size by Type (2020-2032)
- 5.2 Global Liposome Drug Delivery Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Liposome Drug Delivery Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Liposome Drug Delivery Market Size by Type
- 6.4 North America Liposome Drug Delivery Market Size by Application
- 6.5 North America Liposome Drug Delivery Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Liposome Drug Delivery Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Liposome Drug Delivery Market Size by Type
- 7.4 Europe Liposome Drug Delivery Market Size by Application
- 7.5 Europe Liposome Drug Delivery Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Liposome Drug Delivery Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Liposome Drug Delivery Market Size by Type
- 8.4 China Liposome Drug Delivery Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Liposome Drug Delivery Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Liposome Drug Delivery Market Size by Type
- 9.4 APAC (excl. China) Liposome Drug Delivery Market Size by Application
- 9.5 APAC (excl. China) Liposome Drug Delivery Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Liposome Drug Delivery Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Liposome Drug Delivery Market Size by Type
- 10.4 Latin America Liposome Drug Delivery Market Size by Application
- 10.5 Latin America Liposome Drug Delivery Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Liposome Drug Delivery Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Liposome Drug Delivery Market Size by Type
- 11.4 Middle East & Africa Liposome Drug Delivery Market Size by Application
- 11.5 Middle East & Africa Liposome Drug Delivery Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Liposome Drug Delivery Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Liposome Drug Delivery Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Liposome Drug Delivery Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Gilead Sciences
- 13.1.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Gilead Sciences Liposome Drug Delivery Product Portfolio
- 13.1.3 Gilead Sciences Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Pacira
- 13.2.1 Pacira Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Pacira Liposome Drug Delivery Product Portfolio
- 13.2.3 Pacira Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Sun Pharmaceutical
- 13.3.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
- 13.3.3 Sun Pharmaceutical Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Johnson & Johnson
- 13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Johnson & Johnson Liposome Drug Delivery Product Portfolio
- 13.4.3 Johnson & Johnson Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Luye Pharma
- 13.5.1 Luye Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Luye Pharma Liposome Drug Delivery Product Portfolio
- 13.5.3 Luye Pharma Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Sigma-Tau
- 13.6.1 Sigma-Tau Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Sigma-Tau Liposome Drug Delivery Product Portfolio
- 13.6.3 Sigma-Tau Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Ipsen (Onivyde)
- 13.7.1 Ipsen (Onivyde) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
- 13.7.3 Ipsen (Onivyde) Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 CSPC
- 13.8.1 CSPC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 CSPC Liposome Drug Delivery Product Portfolio
- 13.8.3 CSPC Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Teva Pharmaceutical
- 13.9.1 Teva Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
- 13.9.3 Teva Pharmaceutical Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Novartis
- 13.10.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Novartis Liposome Drug Delivery Product Portfolio
- 13.10.3 Novartis Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Fudan-Zhangjiang
- 13.11.1 Fudan-Zhangjiang Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
- 13.11.3 Fudan-Zhangjiang Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Liposome Drug Delivery Industry Chain Analysis
- 14.2 Liposome Drug Delivery Industry Raw Material and Suppliers Analysis
- 14.2.1 Liposome Drug Delivery Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Liposome Drug Delivery Typical Downstream Customers
- 14.4 Liposome Drug Delivery Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook